|

HPV Self-sampling in the General Population

RECRUITINGN/ASponsored by International Agency for Research on Cancer
Actively Recruiting
PhaseN/A
SponsorInternational Agency for Research on Cancer
Started2025-06-26
Est. completion2026-06-30
Eligibility
Age30 Years – 65 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06749847

Summary

A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.

Eligibility

Age: 30 Years – 65 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women aged 30 to 65 years old
* Living in the study area (Departments of Marne and Aube, France)
* At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)

Exclusion Criteria:

* Outside the target age (less than 30 years old, or 66 years old and more)
* Already participating in the current screening round
* Total hysterectomy
* History of cervical cancer
* Current follow-up for abnormal cervical screening result or cervical lesions

Conditions2

CancerCervical Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.